Paradox Interactive AB (0GDU)
London Exchange · UK · prices in SEK · close of 21 Oct 2026
Key indicators
| Last close | SEK 140.60 |
|---|---|
| 52-week range | 110.27 – 181.06 |
| Return, 1 month / 3 months | −10.0% / +11.5% |
| Return, 1 year / 3 years | −11.5% / −40.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 40.7% |
| Worst drawdown (1 year) | -36.7% |
| Average daily value traded | 0.85M SEK |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Paradox Interactive is a Swedish video game company based in Stockholm that develops and publishes strategy games for personal computers and consoles. Its own studios create grand strategy titles in series such as Crusader Kings, Europa Universalis, Hearts of Iron and Stellaris, while the company also publishes games made by other independent developers. Its customers are players around the world who buy its games through digital storefronts, and it also offers downloadable content that expands its existing titles.
Paradox Interactive AB trades under the code 0GDU on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Paradox Interactive AB (0GDU) trades on the London Exchange in UK. It last closed at SEK 140.60 on 21 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,615 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.5% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.3% | ||
| From 52-week high | -21.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 17.3% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.7% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.85M SEK | ||
| Zero-volume days | 6.7% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | −10.0% |
| 3 months | +11.5% |
| 6 months | +17.3% |
| 1 year | −11.5% |
| 3 years | −40.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 144.57 / 136.17 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | SEK 5.0000 |
| 15 May 2025 | SEK 3.0000 |
| 16 May 2024 | SEK 3.0000 |
| 19 May 2023 | SEK 2.0000 |
| 11 May 2022 | SEK 1.0000 |
| 19 May 2021 | SEK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.